Publisher Correction: Allogeneic BCMA-targeting CAR T cells in relapsed/refractory multiple myeloma: phase 1 UNIVERSAL trial interim results.

Sham MailankodyJeffrey V MatousSaurabh ChhabraMichaela LiedtkeSurbhi SidanaOlalekan O OluwoleShahbaz MalikRajneesh NathFaiz AnwerJose Carlos CruzMyo HtutErin E KarskiWade LovelaceMyles DillonEric ButzWendy YingArun BalakumaranShaji K Kumar

Published in: Nature medicine (2023)

Keyphrases

multiple myeloma
stem cell transplantation
phase iii
study protocol
bone marrow
phase ii
clinical trial
cancer therapy
hematopoietic stem cell
high dose
acute lymphoblastic leukemia
randomized controlled trial
diffuse large b cell lymphoma
hodgkin lymphoma
low dose
drug delivery